US Broker Ratings

Astrana Health Inc. (ASTH) Stock Analysis: A Compelling 89% Upside Potential in the Healthcare Sector

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is currently trading at $25.28, with investors keenly watching its potential for growth. With..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 74.25% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices, has been drawing attention with its innovative solutions tailored..

Teladoc Health, Inc. (TDOC) Investor Outlook: A 21% Potential Upside Amidst Mixed Ratings

Teladoc Health, Inc. (TDOC), a pioneering entity in the health information services sector, provides a wide array of virtual healthcare services globally. As the healthcare industry..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Powerhouse with Nearly 200% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. Based in Singapore, this clinical-stage company..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring the 50% Upside Potential in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector with its innovative approach to providing outpatient mental health services across the United..

Indivior PLC (INDV) Stock Analysis: Exploring a 9.21% Potential Upside Amidst Strategic Developments

Indivior PLC (INDV) stands at a pivotal juncture in its journey within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic..

Viridian Therapeutics, Inc. (VRDN): Analyst Ratings Reveal 157% Upside Potential in Biotech Innovator

Viridian Therapeutics, Inc. (VRDN), a biotech company focused on developing novel treatments for rare and serious diseases, has captured the attention of investors with its promising..

Harrow, Inc. (HROW) Investor Outlook: Analyst Ratings Shine Amid 81% Potential Upside

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector specializing in ophthalmic pharmaceuticals, is capturing investor attention with significant potential gains on the horizon...

agilon health, inc. (AGL) Investor Outlook: Assessing Growth Potential Amid an 86% Upside

Agilon health, inc. (NYSE: AGL), a prominent player in the healthcare sector, specializes in providing comprehensive care solutions for seniors through primary care networks across the..

Veracyte, Inc. (VCYT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 47%

Veracyte, Inc. (VCYT), a healthcare company specializing in diagnostics and research, has caught the attention of investors with its promising growth potential. Headquartered in South San..

MiMedx Group, Inc (MDXG) Investor Outlook: Potential 86% Upside Makes This Biotech Stock an Intriguing Bet

MiMedx Group, Inc (NASDAQ: MDXG) is a biotechnology company specializing in healthcare solutions, with a focus on developing placental tissue allografts for medical applications. Headquartered in..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A 162% Potential Upside Captures Investor Attention

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a notable player in the biotechnology sector, has been capturing the attention of investors with its focus on rare disease treatments...

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 142% Potential Upside with Strong Buy Ratings

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is making waves in the biotechnology sector with its promising clinical-stage developments, particularly its flagship product candidate, lorundrostat. With a market..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 24.77% Potential Upside for Investors

Schrodinger, Inc. (NASDAQ: SDGR) is capturing the attention of investors with its promising potential upside of 24.77%, as indicated by the latest analyst ratings. Operating at..

Sotera Health Company (SHC) Stock Analysis: Unlocking a 20% Upside Potential

Sotera Health Company (NASDAQ: SHC) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the diagnostics and research industry. Headquartered in..

Galapagos NV (GLPG) Stock Analysis: Navigating Biotech’s Challenges with a 1.11% Potential Upside

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making headlines with its innovative focus on oncology and immunology. With a market capitalization of $1.88 billion,..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a noteworthy player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With a..

NeoGenomics, Inc. (NEO) Investor Outlook: A 48.81% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, specializes in diagnostics and research with a particular focus on cancer testing. Headquartered in Fort..

Metsera, Inc. (MTSR) Stock Analysis: A 54.66% Upside in the Biotech Arena

Metsera, Inc. (MTSR), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its ambitious focus on tackling obesity and related diseases..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a 155% Potential Upside in the Biotech Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a trailblazer in the biotechnology sector, has been capturing the attention of investors with its focus on developing treatments for muscle..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds